Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report.
aldosterone
cortisol
endometriosis
hypertension
inflammation
mineralocorticoid receptor
spironolactone
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Dec 2022
24 Dec 2022
Historique:
received:
03
11
2022
revised:
19
12
2022
accepted:
21
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
11
1
2023
Statut:
epublish
Résumé
Endometriosis is a chronic inflammatory disease associated with pelvic pain, infertility, and increased cardiovascular risk. Recent studies suggest a possible role of aldosterone as a pro-inflammatory hormone in the pathogenesis of the disease. Cortisol is also an important mediator of stress reaction, but its role is controversial in endometriosis. The aim of this study was to evaluate aldosterone and cortisol levels and blood pressure values in women with endometriosis. We measured blood pressure, plasma aldosterone, renin, cortisol, and dehydroepiandrosterone sulfate (DHEAS) in 20 women with untreated minimal or mild pelvic endometriosis compared with 20 healthy controls matched for age and body mass index. Aldosterone values were similar in the two groups, while renin was significantly lower and the aldosterone to renin ratio was significantly higher in patients with endometriosis than in controls. Systolic blood pressure was in the normal range, but significantly higher in patients with endometriosis. Morning plasma cortisol was normal, but significantly lower in patients with endometriosis compared with controls, while DHEAS to cortisol ratio was similar in the two groups. These preliminary results are evidence of increased biological aldosterone activity and dysregulation of the hypothalamic-pituitary-adrenal axis in early stages of endometriosis. These alterations could play a role in disease development, suggesting new therapeutic targets for aldosterone receptor blockers.
Identifiants
pubmed: 36613755
pii: ijms24010310
doi: 10.3390/ijms24010310
pmc: PMC9820500
pii:
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Aldosterone
4964P6T9RB
Renin
EC 3.4.23.15
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Biomed Res Int. 2015;2015:158490
pubmed: 26064879
Lancet. 2004 Nov 13-19;364(9447):1789-99
pubmed: 15541453
Stress. 2008 Sep;11(5):390-7
pubmed: 18800310
J Reprod Biol Health. 2015;3:
pubmed: 26900480
Fertil Steril. 2010 Oct;94(5):1616-21
pubmed: 20153468
Fertil Steril. 1997 May;67(5):817-21
pubmed: 9130884
Braz J Med Biol Res. 2006 Aug;39(8):1121-7
pubmed: 16906287
Psychoneuroendocrinology. 2018 Mar;89:216-222
pubmed: 29414035
Int J Reprod Biomed. 2016 Jan;14(1):1-8
pubmed: 27141542
Endocrine. 2003 Nov;22(2):113-8
pubmed: 14665714
Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:1-15
pubmed: 30017581
Gynecol Endocrinol. 2010 May;26(5):372-7
pubmed: 20050763
G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.12
pubmed: 26913880
Nat Rev Endocrinol. 2009 Jul;5(7):374-81
pubmed: 19488073
Cell Death Dis. 2020 Aug 13;11(8):679
pubmed: 32826848
Br Med J (Clin Res Ed). 1983 May 7;286(6376):1489-93
pubmed: 6405856
Obstet Gynecol. 2019 Sep;134(3):527-536
pubmed: 31403584
Hypertension. 2017 Jul;70(1):59-65
pubmed: 28559401
Expert Opin Pharmacother. 2016 Sep;17(13):1713-5
pubmed: 27450358
Psychoneuroendocrinology. 2000 Jan;25(1):1-35
pubmed: 10633533
J Clin Hypertens (Greenwich). 2018 Apr;20(4):727-729
pubmed: 29569322
Eur Heart J Open. 2022 Feb 02;2(1):oeac001
pubmed: 35919664
Front Endocrinol (Lausanne). 2019 Aug 23;10:575
pubmed: 31507531
Circulation. 2007 Jul 17;116(3):268-75
pubmed: 17606839
Eur J Endocrinol. 1999 Sep;141(3):279-85
pubmed: 10474126
Int J Mol Sci. 2021 May 11;22(10):
pubmed: 34064854
Steroids. 2012 May;77(6):655-8
pubmed: 22387621
Int J Mol Sci. 2022 Apr 08;23(8):
pubmed: 35456928
N Engl J Med. 2017 May 11;376(19):1881-1882
pubmed: 28489997
J Clin Endocrinol Metab. 1992 Apr;74(4):946-9
pubmed: 1312543
Endocr Metab Immune Disord Drug Targets. 2022 May 09;:
pubmed: 35532249
Hypertension. 2018 Aug;72(2):263-269
pubmed: 29941519
Reprod Sci. 2020 Sep;27(9):1675-1686
pubmed: 32542543
J Clin Endocrinol Metab. 2013 Jun;98(6):2494-501
pubmed: 23539731
Lab Invest. 2014 Aug;94(8):839-50
pubmed: 24862968
Am J Physiol. 1985 Mar;248(3 Pt 1):E388-90
pubmed: 3156509
J Minim Invasive Gynecol. 2022 Nov 18;:
pubmed: 36403695
J Steroid Biochem Mol Biol. 2015 Jan;145:213-25
pubmed: 25008465
Annu Rev Physiol. 2022 Feb 10;84:585-610
pubmed: 35143332
J Clin Endocrinol Metab. 2004 Apr;89(4):1973-6
pubmed: 15070972
High Blood Press Cardiovasc Prev. 2016 Jun;23(2):69-72
pubmed: 26971505
Curr Opin Pharmacol. 2001 Apr;1(2):190-6
pubmed: 11714095
J Clin Hypertens (Greenwich). 2017 Nov;19(11):1060-1062
pubmed: 28834202
J Endocrinol. 1999 Dec;163(3):425-31
pubmed: 10588816
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683